Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Green Thumb Industries Inc C.GTII

Alternate Symbol(s):  GTBIF

Green Thumb Industries Inc. is a cannabis consumer packaged goods company. It is a retailer, which promotes well-being through the power of cannabis while giving back to the communities in which it serves. It has two segments: Retail and Consumer Packaged Goods. The Company owns, manufactures and distributes a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomons, Good Green, incredibles and RYTHM, to third-party retail stores across the United States, as well as to its own retail stores. It also owns and operates retail cannabis stores that include a national chain called RISE Dispensaries, as well as retail stores operating under other names. Its retail stores sell a combination of its products and third-party products. It operates in 14 United States markets, including California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia.


CSE:GTII - Post by User

Comment by Bullknit101on Feb 04, 2022 7:41am
114 Views
Post# 34396494

RE:Stifel 2022 Top Picks

RE:Stifel 2022 Top PicksFunny how all these reports come out and the stock tanks. Analyst don't seem to be accountable for their forecasts but they certainly can lose credibility. Another strategy might be to sell when these lofty price targets come out and then buy when the dowbward forecasts come out. Of course, I know retail is selling and US Cannabis reform is slow as molasses. So many ironies - where's the health freedom in Cannabis??
<< Previous
Bullboard Posts
Next >>